Optimum number of oocytes for a successful first IVF treatment cycle

Reproductive BioMedicine Online

Volumn 13, Issue 4, 2006, Pages 476-480

  van der Gaast, Mark H ^a   Eijkemans, M J C ^a   van der Net, J B ^a   de Boer, E J ^b   Burger, C W ^a   van Leeuwen, F E ^c   Fauser, B C J M ^a,d   Macklon, N S ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

IVF; Oocytes; Optimum; Ovarian stimulation; Pregnancy

Indexed keywords

GONADORELIN AGONIST; GONADOTROPIN;

ADULT; AGE; ARTICLE; CELL COUNT; CLINICAL PROTOCOL; CONCEPTION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO TRANSFER; FEMALE; FEMALE FERTILITY; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NATURAL SELECTION; OOCYTE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; TREATMENT OUTCOME;

EID: 33749673961     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60633-5     Document Type: Article

References (27)

1. Baart EB, Martini E, van de Berg I et al. 2006 Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF. Human Reproduction 12, 223-233.
2. Bourgain C, Devroey P 2003 The endometrium in stimulated cycles for IVF. Human Reproduction Update 9, 515-22.
3. Devroey P, Bourgain C, Macklon NS et al. 2004 Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinology and Metabolism 15, 84-90.
4. de Boer EJ, van Leeuwen FE, den Tonkelaar I et al. 2004 Methods and results of in-vitro fertilisation in the Netherlands in the years 1983-1994. Nederlands Tijdschrift voor Geneeskunde 148, 1448-1455.
5. Edwards RG 2003 Towards single births after assisted reproduction treatment. Reproductive BioMedicine Online 7, 506-508.
6. Edwards RG, Lobo R, Bouchard P 1996 Time to revolutionize ovarian stimulation. Human Reproduction 11, 917-919.
7. Fauser BC, Macklon NS 2004 Medical approaches to ovarian stimulation for infertility. In: Strauss JF, III, Mastroianni L Jr, (eds) Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. Elsevier-Saunders Philadelphia, pp.965-1012.
8. Fauser BC, Devroey P, Macklon NS 2005 Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 365, 1807-1816.
9. Fauser BC, Devroey P, Yen SS et al. 1999 Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Human Reproduction 14, 2681-2686.
10. Greb RR, Behre HM, Simoni M 2005 Pharmacogenetics in ovarian stimulation - current concepts and future options. Reproductive BioMedicine Online 11, 589-600.
11. Hohmann FP, Macklon NS, Fauser BC 2003 A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. Journal of Clinical Endocrinology and Metabolism 88, 166-173.
12. Klip H, Burger CW, de Kraker J, van Leeuwen FE 2001 Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Human Reproduction 16, 2451-2458.
13. Kodaman PH, Taylor HS 2004 Hormonal regulation of implantation. Obstetrics and Gynecology Clinics of North America 31, 745-766.
14. Macklon NS, Fauser BC 2000a Impact of ovarian hyperstimulation on the luteal phase. Journal of Reproduction and Fertility 55, 101-108.
15. Macklon NS, Fauser BC 2000b Regulation of follicle development and novel approaches to ovarian stimulation for IVF. Human Reproduction Update 6, 307-312.
16. Macklon NS, Stouffer RL, Giudice LC, Fauser BC 2006 The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocrine Review 27, 170-270.
17. Munné S 2006 Chromosome abnormalities and their relationship to morphology and development of human embryos. Reproductive BioMedicine Online 12, 234-253.
18. Pena JE, Chang PL, Chan LK et al. 2002 Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles. Human Reproduction 17, 83-87.
19. Popovic-Todorovic B, Loft A, Bredkjaeer HE et al. 2003 A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment. Human Reproduction 18, 2275-2282.
20. Sharma V, Allgar V, Rajkhowa M 2002 Factors influencing the cumulative conception rate and discontinuation of in vitro fertilization treatment for infertility. Fertility and Sterility 78, 40-46.
21. Símon C, Garcia VJ, Valbuena D et al. 1998 Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen. Fertility and Sterility 70, 234-239.
22. Símon C, Cano F, Valbuena D et al. 1995 Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Human Reproduction 10, 2432-2437.
23. Tarlatzis BC, Zepiridis L, Grimbizis G et al. 2003 Clinical management of low ovarian response to stimulation for IVF: a systematic review. Human Reproduction Update 9, 61-76.
24. Templeton A, Morris JK, Parslow W 1996 Factors that affect outcome of in-vitro fertilisation treatment. The Lancet 348, 1402-1406.
25. Valbuena D, Jasper M, Remohi J et al. 1999 Ovarian stimulation and endometrial receptivity. Human Reproduction 14, 107-111.
26. van der Gaast MH, Beckers NG et al. 2002 Ovarian stimulation for IVF and endometrial receptivity - the missing link. Reproductive BioMedicine Online 5, 36-43.
27. Yih MC, Spandorfer SD, Rosenwaks Z 2005 Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories. Fertility and Sterility 83, 24-29.